Andrew Sheets: Optimism for Credit Markets
Even as economic and public health data get worse, recent changes in three key factors make global credit markets an attractive option. Our Chief Cross-Asset Strategist, Andrew Sheets, explains.
3 Huhti 20202min
Michael Zezas: What Does the CARES Act Buy?
The $2 trillion CARES Act includes a variety of provisions that will help preserve the financial health of state and local governments, hospitals and airports. Here’s what’s inside.
1 Huhti 20202min
Mike Wilson: U.S. Equities - Is the Worst Behind Us?
Although economic and earnings data could be gloomy over the next month, have equity markets already discounted the bad news? Detailed analysis from Chief Investment Officer Mike Wilson.
30 Maalis 20203min
Andrew Sheets: The Critical Calls of Financial Referees
Governments and central banks face two issues: A flight to liquidity and a global economy that showed signs of fatigue even before the pandemic. For investors seeking opportunities, it’s an important distinction.
27 Maalis 20203min
Special Episode: Can $2 Trillion Flatten the Unemployment Curve?
As a record 3.28 million workers file for unemployment, our Chief U.S. Economist and Chief U.S. Public Policy researcher weigh potential effects from the fiscal package now before Congress.
26 Maalis 20206min
Michael Zezas: Sizing Up the Stimulus Package
Congressional leaders have reached a deal on a $2 trillion stimulus bill to deal with fallout from the coronavirus crisis. Will it work? Two criteria to watch for.
25 Maalis 20202min
Mike Wilson: The Underlying Reasons for Recession
Mike Wilson looks beyond the coronavirus outbreak at the two key conditions which have made the markets vulnerable to a recession.
23 Maalis 20203min
Andrew Sheets: First, Improve on Uncertainty
On this episode, Chief Cross-Asset Strategist Andrew Sheets says that the 4%+ swings in equities markets have made investors skeptical about jumping back in. More U.S. testing could help.
20 Maalis 20203min
